03/03/2014 - 12:26pm

AstraZeneca received approval from the Food and Drug Administration for its Bydureon pen (exenatide extended-release for injectable suspension) 2-mg, which is to be used as an addition to diet and exercise to improve glycemic control in adults with Type 2 diabetes.

02/12/2014 - 11:46am

America’s biopharmaceutical research companies currently are developing 180 new medicines to help the nearly 400 million people who have diabetes worldwide, the Pharmaceutical Research and Manufacturers of America announced Tuesday.

02/07/2014 - 11:02am

The United States Hispanic Chamber of Commerce welcomed Boehringer Ingelheim Pharmaceuticals to its family of corporate members as a strategic partner.

01/21/2014 - 1:31pm

Novo Nordisk has launched a new insulin pen designed for children with diabetes.

01/14/2014 - 3:58pm

A physician in Mississippi is warning that one-third of the state's population could have diabetes in less than two decades, according to published reports.

01/08/2014 - 1:47pm

The Food and Drug Administration has approved a new drug made by Bristol-Myers Squibb and AstraZeneca for treating Type 2 diabetes, the agency said.

12/12/2013 - 2:25pm

Diabetes organizations in several cities are getting a boost in funding from a Danish drug maker that specializes in developing treatments for the disease.

11/25/2013 - 3:59pm

Federal regulators are lifting some restrictions on a diabetes drug that were placed two years ago after studies linked the drug to increased cardiovascular risk.

11/07/2013 - 1:00pm

A former executive from Cisco has been appointed as CEO of the International Diabetes Federation.